Wire · opportunities
AZ, Oracle partner for AI-powered clinical trials; FDA approves Haemonetics vascular closure system
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 20 October 2026 · Fusion42 review
AstraZeneca has partnered with Oracle to use AI in clinical trials, while the FDA has approved a vascular closure system from Haemonetics. This signals regulatory acceptance of AI tools in drug development trials and ongoing medical device approvals.
This Wire brief sits within Fusion42's coverage of Biotech, and 5 sources have reported it.
◆ ◆ The Wire takeaway
You must adapt trial designs to incorporate AI tools as regulatory bodies start endorsing AI-driven clinical development. Approval of new medical devices like Haemonetics' vascular closure system opens immediate avenues for device innovators to engage US healthcare providers.
◆ Coverage
5 sources · 20 Oct 2026
◆ Related on Wire
◆ Topics